On this episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by Professor Rob Wynn, Consultant Paediatric Haematologist and Director of Blood and Bone Marrow Transplantation at Manchester Children’s Hospital.What’s in this episode:- Rob’s journey into medicine and how a last-minute decision at sixth form led him to a career in paediatric haematology- Why haematology appealed to him as a specialty, combining both the science and philosophy of medicine- The remarkable advances he has witnessed in childhood blood cancer treatment during more than 30 years in the field- Why giving families hope, alongside honesty, is essential when a child is diagnosed with leukaemia- What a true cure means to Rob, and the importance of helping children live healthy, normal lives after treatment- The role of blood and bone marrow transplantation in treating childhood blood cancers and the potential of cord blood donations- How immunotherapy, targeted treatments and transplantation are creating new options when chemotherapy alone is not enough- The motivation that continues to drive his work, including improving outcomes and reducing treatment-related side effects- His vision for the future through the ATICUS Network, with a focus on curing every child while minimising toxicity- The story behind completing Tour 21 despite breaking his elbow on day two, and why supporting blood cancer research remains so importantFind out more about Cure Leukaemia and how you can support pioneering blood cancer research and patients across the globe: https://www.cureleukaemia.co.uk/

On this episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by James McLaughlin, Chief Executive of Cure Leukaemia.

What’s in this episode:

• James’ route into Cure Leukaemia, from his career in sport with organisations including Nike, Watford FC and Edgbaston Cricket Club
• How meeting Cure Leukaemia co-founders Professor Charlie Craddock and Graham Silk inspired him to join the charity’s mission
• Why his commercial and marketing background has helped drive the charity’s growth and fundraising success
• The importance of keeping patients at the heart of every decision and seeing first-hand the impact of clinical research
• The partnerships and fundraising milestones that helped transform Cure Leukaemia
• The story behind Tour 21 and the moment Cure Leukaemia came within “an hour of going bust”
• James’ vision for the future, including expanding access to clinical trials and growing the ATICUS Network to improve treatment options for children with blood cancer

Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠⁠https://www.cureleukaemia.co.uk/⁠

On this special International Clinical Trials Day episode of Let’s Talk Blood Cancer, The Patients’ Podcast, we are joined by Professor Chris Fox, Professor of Haematology at Nottingham University Hospitals and Medical Director of the Trials Acceleration Programme (TAP), to discuss the vital role clinical trials play in advancing blood cancer treatment and improving patient outcomes.

What’s in this episode:

• Professor Fox’s journey into haematology and lymphoma, and the differences between lymphoma and leukaemia
• How he balances patient care with leading and designing clinical trials to bring new treatments to patients
• Why clinical trials are essential for developing safer and more effective therapies for blood cancers
• The major advances transforming lymphoma treatment, including immunotherapy, CAR-T cell therapy, and bispecific antibodies
• The impact of the Trials Acceleration Programme (TAP) in improving access to pioneering clinical trials across the UK
• Why Professor Fox believes the future of lymphoma treatment is incredibly promising, with continued progress expected over the next decade

Find out more about Cure Leukaemia and how you can get involved and support blood cancer patients across the globe: ⁠⁠https://www.cureleukaemia.co.uk/⁠